Cargando…
Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe: results from the DRIVE multi-stakeholder study platform
INTRODUCTION: Development of Robust and Innovative Vaccine Effectiveness (DRIVE) was a European public–private partnership (PPP) that aimed to provide annual, brand-specific estimates of influenza vaccine effectiveness (IVE) for regulatory and public health purposes. DRIVE was launched in 2017 under...
Autores principales: | Stuurman, Anke L., Carmona, Antonio, Biccler, Jorne, Descamps, Alexandre, Levi, Miriam, Baum, Ulrike, Mira-Iglesias, Ainara, Bellino, Stefania, Hoang, Uy, de Lusignan, Simon, Bonaiuti, Roberto, Lina, Bruno, Rizzo, Caterina, Nohynek, Hanna, Díez-Domingo, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399959/ https://www.ncbi.nlm.nih.gov/pubmed/37546295 http://dx.doi.org/10.3389/fpubh.2023.1195409 |
Ejemplares similares
-
Investigating confounding in network‐based test‐negative design influenza vaccine effectiveness studies—Experience from the DRIVE project
por: Stuurman, Anke L., et al.
Publicado: (2022) -
Challenges and Adaptation of a European Influenza Vaccine Effectiveness Study Platform in Response to the COVID-19 Emergence: Experience from the DRIVE Project
por: Carmona, Antonio, et al.
Publicado: (2021) -
Investigating the procurement system for understanding seasonal influenza vaccine brand availability in Europe
por: Stuurman, Anke L., et al.
Publicado: (2021) -
Factors driving choices between types and brands of influenza vaccines in general practice in Austria, Italy, Spain and the UK
por: Stuurman, Anke L., et al.
Publicado: (2021) -
Feasibility of Point-of-Care Testing for Influenza Within a National Primary Care Sentinel Surveillance Network in England: Protocol for a Mixed Methods Study
por: de Lusignan, Simon, et al.
Publicado: (2019)